Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian

Print Friendly, PDF & Email

A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research.  Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the Newly FDA Approved Medicine.

Date: 07/25/2020

Camille Bedrosian & Bridget Reineking

Listen Now: Click Here

Related Articles